InvestoGain Australia

SEARCH LISTED COMPANY

ANY AUS OR NZ COMPANY

BROWSE

Browse Australian listed companies

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

BROWSE

Browse Australian listed companies

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Browse Australian delisted companies/archived funds or use SEARCH

SEARCH PRIVATE COMPANY

SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

TRIVARX LTD(TRI)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

 FROMTO
TRIVARX LTD16/10/2023
MEDIBIO LIMITED01/12/201416/10/2023
BIOPROSPECT LIMITED01/12/2014

Shareholder links

Our website ranking of TRI: rating 1
(1 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Level 5, 126 Philip Street Sydney NSW 2000 GPO Box 5193 Sydney NSW 2001

Tel : 1300 288 664 or +61 2 9698 5414
Fax : +61 2 8583 3040
RegistryWebsite RegistryEmail

Company details

ISIN: AU0000300196
Address: 647 Beaufort Street, Mt Lawley WA 6050
Tel:  +61 8 6189 1155 Fax: +613 9077 9233

Date first listed: 29/01/2001
Company Secretary: 
Sector: Health Care Equipment and Services Industry Group: XHJ
Activities: Development of diagnostic heart rate variability technology for mental health diagnosis

News & Events

Expand this box to read and print

The suspension of trading in the securities of TrivarX Limited will be lifted immediately following the release by TRI of an announcement regarding a material acquisition and a capital raising.

16/10/2025

The company plans to acquire 100% of Stabl-Im technology from Nucleics Pty Ltd for effective brain tumour detection. The technology enables safe imaging via stable isotope labelling, addressing the limited treatment options for brain metastases affecting 20% of adult cancer patients. A $4.2m placement has been secured to advance manufacturing, FDA engagement, and clinical trials.

16/10/2025

The company advises that the current voluntary trading suspension will continue until we are in a position to make an announcement regarding a material acquisition and potential capital raising, which is expected to be by 17 October.

13/10/2025

The company's securities suspended pending announcement, per Listing Rule 17.2 request.

09/10/2025

name changed from Medibio Limited

16/10/2023

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    Posting your comments. Please wait...

     

    Click here for free access to this company's:
    ASX, Legal & CGT Status

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    09/11/2018Chris Indermaur200,000$0.040$8,000.00
    06/11/2018Andrew Maxwell216,002$0.044$9,434.00
    02/08/2017Andrew Maxwell26,000$0.380$9,880.00
    10/07/2017Peter Carlisle5,500$0.373$2,053.00
    18/04/2017Jack Cosentino100,000$0.370$37,000.00

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    David TrimboliNon Exec Chairman25/08/2022
    Lisa HeineNon Exec Director29/08/2019
    John MathiasNon Exec Director01/10/2024
    Silvio SalomNon Exec Director13/11/2022
    Chris NtoumenopoulosNon Exec Director15/02/2023
    Anthony KeatingExecutive Director29/07/2024
    Stephen BuckleyCompany Secretary

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION

    Date of first appointment, title may have changed.